These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 13782625)

  • 1. [Heparin tolerance and blood coagulation factors in obliterating arteriopathy].
    WALCHER A; GOOSSENS N; HESS H; STUMPF W
    Klin Wochenschr; 1960 Sep; 38():952. PubMed ID: 13782625
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intra-arterial therapy in arteriopathy of the lower extremities].
    TESSAROLO N; SGOIFO S
    Acta Chir Ital; 1960; 16():227-40. PubMed ID: 13776075
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intra-arterial heparin therapy of obliterative disorders of the vascular wall].
    OROSZ L; KELENTEY B
    Orv Hetil; 1962 Aug; 103():1503-7. PubMed ID: 14482343
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experiments in various circulation disorders with H.A.H. (heacrin)].
    SZIRMAI E; TURKALJ I; AVELINI I
    Z Gesamte Inn Med; 1961 Feb; 16():141. PubMed ID: 13774609
    [No Abstract]   [Full Text] [Related]  

  • 5. Thrombelastographic studies with a twenty-four-hour schedule for subcutaneous heparin. A comparison of its efficiency with prothrombin-depressing agents.
    ELIOT RS; VON KAULLA KN; BLOUNT SG
    Circulation; 1961 Nov; 24():1206-14. PubMed ID: 13889849
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences with the heparinoid-luronase ointment Lasonil as a basic theapeutic agent].
    GRUSCHINSKE G
    Dtsch Med J; 1962 May; 13():297-8. PubMed ID: 13902471
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic innovations in chronic peripheral arteriosclerotic obliterating arteriopathies].
    GUAGLIANO G; STOPPANI L; CONTI PG
    Angiologia; 1960; 12():323-36. PubMed ID: 13709323
    [No Abstract]   [Full Text] [Related]  

  • 8. [Contribution to the study of thrombophilia in chronic obliterating arteriopathy of the extremities].
    VERGANI G; SIDERI GC
    Osp Maggiore; 1961 May; 49():209-18. PubMed ID: 13780845
    [No Abstract]   [Full Text] [Related]  

  • 9. Heparin resistance determined by the heparin tolerance test in patients treated with phenylindanedione before, during, and after operation.
    GORMSEN J; HAXHOLDT BF
    Acta Chir Scand; 1961; 121():367-76. PubMed ID: 13707283
    [No Abstract]   [Full Text] [Related]  

  • 10. [Correlation of physiological inhibitors of blood coagulation to activity fluctuations of pathologically decreased blood coagulation factors].
    SCHIMPF K; LENHARD J; OSAMO NO
    Folia Haematol (Frankf); 1961 Oct; 6():321-4. PubMed ID: 14498426
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anticoagulant therapy of chronic obliterating peripheral arteriopathy].
    TATTONI G; MALCHIODI C
    Arch Ital Chir; 1954; 77(3):169-88. PubMed ID: 13181602
    [No Abstract]   [Full Text] [Related]  

  • 12. [On blood hypercoagulability following the anticoagulant effect of heparin].
    BOCCARDI V; DERIU L
    Prog Med (Napoli); 1961 Sep; 17():607-14. PubMed ID: 13870323
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes of the arteriolo-capillary circulation in subjects of chronic peripheral obliterating arteriopathy after treatment with 1, 1-(beta-hydroxypropyl)-theobromine].
    GUAGLIANO G; STOPPANI L; VITTORI F
    Minerva Med; 1959 Nov; 50():3815-9. PubMed ID: 13829927
    [No Abstract]   [Full Text] [Related]  

  • 14. The anti-heparin, anticoagulant and hypotensive properties of hexadimethrine and protamine.
    EGERTON WS; ROBINSON CL
    Lancet; 1961 Sep; 2(7203):635-7. PubMed ID: 13725907
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the use of the gastric mucoprotein in chronic obliterating arteriopathy of the extremities].
    MORPURGO M
    G Gerontol; 1960 Nov; 8():1013-5. PubMed ID: 13772793
    [No Abstract]   [Full Text] [Related]  

  • 16. [THE PHYSIOLOGIC INHIBITORS OF BLOOD COAGULATION IN PATHOLOGICALLY INCREASED COAGULABILITY IN VIVO. II. SERUM INFUSION INTO THE BLOOD STREAM].
    SCHIMPF K; CIBELIUS A; MARDINI R
    Klin Wochenschr; 1964 Jul; 42():637-40. PubMed ID: 14248608
    [No Abstract]   [Full Text] [Related]  

  • 17. [Heparin activity before and after iodized salt-water balneotherapy with protamine sulfate index and coagulation time].
    FORTUNA A
    Arch Med Interna; 1959; 11():225-34. PubMed ID: 13824073
    [No Abstract]   [Full Text] [Related]  

  • 18. [Regional changes of blood coagulation in chronic obliterating peripheral arteriopathy].
    BASSI M; CERRA R
    G Ital Chir; 1955 Apr; 11(4):380-91. PubMed ID: 14391704
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of the antilipemic and anticoagulant activity of a heparin derivative].
    REGAZZINI A; RODARI T
    Rass Fisiopatol Clin Ter; 1961 Apr; 33():301-16. PubMed ID: 14491056
    [No Abstract]   [Full Text] [Related]  

  • 20. Heparin in blood clotting and thrombosis.
    BEST CH; JAQUES LB
    Ann N Y Acad Sci; 1948 May; 49(Art 4):501-17. PubMed ID: 18915056
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.